<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_2020_03_24_992230v1/results/search/disease/results.xml">
  <result pre="like aciclovir and zidovudine block viral reverse transcriptase to treat" exact="herpes simplex" post="virus and HIV infections, respectively, and RNA-dependent RNA polymerase"/>
  <result pre="(RdRp) inhibitors like dasabuvir and sofosbuvir are used to treat" exact="hepatitis" post="C virus infections ( Nováková et al., 2018). More"/>
  <result pre="was tested in infected or uninfected cultures of the A549" exact="lung carcinoma" post="cell line ( Figure 5 A ). In all"/>
  <result pre="Advances in the development of nucleoside and nucleotide analogues for" exact="cancer" post="and viral diseases. Nat. Rev. Drug Discov. 12, 447–"/>
  <result pre="(4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and" exact="hepatitis" post="C virus replication in cell culture. J. Biol. Chem."/>
  <result pre="( 2008). 2′-deoxy-4′-azido nucleoside analogs are highly potent inhibitors of" exact="hepatitis" post="C virus replication despite the lack of 2′-α-hydroxyl groups."/>
  <result pre="their analysis in biological materials – Part II: Antivirals against" exact="hepatitis" post="and HIV viruses. J. Pharm. Biomed. Anal. 147, 378–"/>
 </snippets>
</snippetsTree>
